A Qualitative Study on Barriers to COVID-19 Vaccine Uptake among Community Members in Tanzania
Abstract
:1. Introduction
2. Materials and Methods
Data Analysis
3. Results
3.1. Sociodemographic Characteristics
3.2. Awareness and Knowledge about the COVID-19 Infection
3.2.1. COVID-19 Discovery and Mode of Transmission
3.2.2. COVID-19 Waves and Their Effects
“In the first wave of COVID-19, people were confused as they didn’t know what to do…if you get a normal cough and you go to the health facility, they will label you as having the disease and they mix you with people who have it and you get it there. In the following waves, the fear was reduced as the test kits for the diseases were made available”.(FGD 1 Vaccinated women, FGD 5 Men—Kilimanjaro region)
“During the very first phase after discovering that this is a disease is in Tanzania and affect people, and the increasing death rate, there was so much fear because it seemed that everyone with this disease will only die, so there was so much fear and because people were not educated and did not have a clear understanding, honestly the first phase was a big problem”.(FGD 1 Vaccinated women—Lindi)
3.3. COVID-19 Risk Perception
“As a leader in the community I meet people with different problems, so what we do we have put a boundary in the office where our clients will stop when we listen to their problems. That is because we are in risk of being infected and infect others”.(IDI 1-Tabora)
3.4. Community Perception of the COVID-19 Disease
3.5. Barriers to the Uptake of the COVID-19 Vaccines
3.5.1. Contradicting Statements from Top Government Leaders
3.5.2. Vaccine Rollout Preceded Education about the COVID-19 Vaccines
3.5.3. Fear/Myths towards COVID-19 Vaccines
“We have heard that if we get the vaccine we will get corona, as most people believe that CORONA is a manmade pandemic so as to reduce global population. Population reduction is one of the agenda so as to fight high population growth in some countries”.(IDI 2—Pemba; FGD 3—Kilimanjaro; FGD 2 Unvaccinated women—Lindi)
3.5.4. Presence of Different Types of COVID-19 Vaccines
3.5.5. The Process of Getting the COVID-19 Vaccines
Signing the Consent Form
Voluntary Uptake of the COVID-19 Vaccines
“Making it voluntary has made it a challenge. If it is important and good for the people then it should be mandatory just like it is with children’s vaccines…”.(FGD 3 Unvaccinated women—Dar es Salaam)
“Others accept it and others do not because it is voluntary. Here people misuse their freedom hence many are not vaccinated”.(FGD 3 Unvaccinated women—Dar es Salaam)
“The response is not so good when you look at the number of people who have taken the vaccine compared to the number of Tanzanians. This may be mainly contributed to the fact that it is voluntary”.(FGD 6 men—Dar es Salaam)
3.5.6. The Role of Social Media and Informal Meeting Places on Vaccine Hesitancy
3.6. Conflicts with Religious Beliefs
“… Yes we have heard about COVID-19 vaccines…but we think it conflicts with our belief in trusting God. So if we vaccinate it means we don’t have hope…we don’t have trust…we leave everything to God’’.(FGD 3 Unvaccinated women—Mbeya)
“In fact, there are those who accept the vaccine and agree to be vaccinated. But there are others who are rigid, their rigidity is based on faith. They will tell you my faith does not allow me to be vaccinated. Someone will tell you we were told to practice steam inhalation. Those ones we will not vaccinate until they are told otherwise by their religious leaders”.(FGD Vaccinated women—Tabora)
4. Discussion
Study Limitation
5. Conclusions and Recommendations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- WHO. Meeting of the Strategic Advisory Group of Experts on Immunization, October 2014—Conclusions and Recommendations; WHO: Geneva, Switzerland, 2014. [Google Scholar]
- WHO. Ten Threats to Global Health. 2019. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed on 15 March 2023).
- Lazarus, J.V.; Wyka, K.; White, T.M.; Picchio, C.A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Ratzan, S.C.; Kamarulzaman, A.; El-Mohandes, A. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat. Med. 2023, 29, 366–375. [Google Scholar] [CrossRef]
- Kabakama, S.; Konje, E.T.; Dinga, J.N.; Kishamawe, C.; Morhason-Bello, I.; Hayombe, P.; Adeyemi, O.; Chimuka, E.; Lumu, I.; Amuasi, J.; et al. Commentary on COVID-19 Vaccine Hesitancy in sub-Saharan Africa. Trop. Med. Infect. Dis. 2022, 7, 130. [Google Scholar] [CrossRef] [PubMed]
- Abay, E.S.; Belew, M.D.; Ketsela, B.S.; Mengistu, E.E.; Getachew, L.S.; Tefere, Y.A.; Zerihun, A.B. Assessment of attitude towards COVID-19 vaccine and associated factors among clinical practitioners in Ethiopia: A cross-sectional study. PLoS ONE 2022, 17, e0269923. [Google Scholar] [CrossRef]
- Mtei, M.; Mboya, I.B.; Mgongo, M.; Manongi, R.; Amour, C.; Bilakwate, J.S.; Nyaki, A.Y.; Ngocho, J.; Jonas, N.; Farah, A.; et al. Confidence in COVID-19 vaccine effectiveness and safety and its effect on vaccine uptake in Tanzania: A community-based cross-sectional study. Hum. Vaccines Immunother. 2023, 19, 2191576. [Google Scholar] [CrossRef] [PubMed]
- Konje, E.T.; Basinda, N.; Kapesa, A.; Mugassa, S.; Nyawale, H.A.; Mirambo, M.M.; Moremi, N.; Morona, D.; Mshana, S.E. The Coverage and Acceptance Spectrum of COVID-19 Vaccines among Healthcare Professionals in Western Tanzania: What Can We Learn from This Pandemic? Vaccines 2022, 10, 1429. [Google Scholar] [CrossRef] [PubMed]
- Msuya, S.E.; Manongi, R.N.; Jonas, N.; Mtei, M.; Amour, C.; Mgongo, M.B.; Bilakwate, J.S.; Amour, M.; Kalolo, A.; Kapologwe, N.; et al. COVID-19 Vaccine Uptake and Associated Factors in Sub-Saharan Africa: Evidence from a Community-Based Survey in Tanzania. Vaccines 2023, 11, 465. [Google Scholar] [CrossRef]
- Haas, E.J.; Angulo, F.J.; Mclaughlin, J.M.; Anis, E.; Singer, S.R.; Khan, F.; Brooks, N.; Smaja, M.; Mircus, G.; Pan, K.; et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data. Lancet 2021, 397, 1819–1829. [Google Scholar] [CrossRef]
- Zeng, B.; Gao, L.; Zhou, Q.; Yu, K.; Sun, F. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: A systematic review and meta-analysis. BMC Med. 2022, 20, 200. [Google Scholar] [CrossRef]
- Tartof, S.Y.; Slezak, J.M.; Fischer, H.; Hong, V.; Ackerson, B.K.; Ranasinghe, O.N.; Frankland, T.B.; Ogun, O.A.; Zamparo, J.M.; Gray, S.; et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. Lancet 2021, 398, 1407–1416. [Google Scholar] [CrossRef]
- Tré-Hardy, M.; Cupaiolo, R.; Wilmet, A.; Antoine-Moussiaux, T.; Della Vecchia, A.; Horeanga, A.; Papleux, E.; Vekemans, M.; Beukinga, I.; Blairon, L. Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary. J. Infect. 2021, 83, 559–564. [Google Scholar] [CrossRef]
- Lawal, L.; Bello, M.A.; Murwira, T.; Avoka, C.; Ma’Aruf, S.Y.; Omonhinmin, I.H.; Maluleke, P.; Tsagkaris, C.; Onyeaka, H. Low coverage of COVID-19 vaccines in Africa: Current evidence and the way forward. Hum. Vaccines Immunother. 2022, 18, e2034457. [Google Scholar] [CrossRef] [PubMed]
- Ackah, B.B.B.; Woo, M.; Stallwood, L.; Fazal, Z.A.; Okpani, A.; Ukah, U.V.; Adu, P.A. COVID-19 vaccine hesitancy in Africa: A scoping review. Glob. Health Res. Policy 2022, 1, 21. [Google Scholar] [CrossRef]
- Hamisi, N.M.; Dai, B.; Ibrahim, M. Global Health Security amid COVID-19: Tanzanian government’s response to the COVID-19 Pandemic. BMC Public Health 2023, 23, 205. [Google Scholar] [CrossRef] [PubMed]
- Voice of Africa. Tanzania president launches COVID-19 vaccination campaign, Africa. Public Health 2021, 194, 25–28. Available online: https://www.voanews.com/a/covid-19-pandemic_tanzania-president-launches-covid-19-vaccination-campaign/6208855.html (accessed on 21 February 2023).
- Chilongola, J.O.; Rwegoshola, K.M.; Balingumu, O.H.; Semvua, H.S.; Edith, T. COVID-19 Knowledge, Attitudes, Practices, and vaccination hesitancy in Moshi. Tanzan. J. Health Res. 2022, 23, 1–12. [Google Scholar]
- Dereje, N.; Tesfaye, A.; Tamene, B.; Alemeshet, D.; Abe, H.; Tesfa, N.; Gedion, S.; Biruk, T.; Lakew, Y. COVID-19 vaccine hesitancy in Addis Ababa, Ethiopia: A mixed-method study. BMJ Open 2022, 12, e052432. Available online: https://bmjopen.bmj.com/content/12/5/e052432 (accessed on 17 March 2023). [CrossRef]
- WHO. WHO and Partners Welcome New Drive to Push COVID-19 Vaccination. 2022. Available online: https://www.afro.who.int/countries/united-republic-of-tanzania/news/who-and-partners-welcome-new-drive-push-covid-19-vaccination (accessed on 17 March 2023).
- Siu, J.Y.-M.; Cao, Y.; Shum, D.H. Perceptions of and hesitancy toward COVID-19 vaccination in older Chinese adults in Hong Kong: A qualitative study. BMC Geriatr. 2022, 22, 288. [Google Scholar] [CrossRef] [PubMed]
- Bono, S.A.; Faria, E.; Villela, D.M.; Siau, C.S.; Chen, W.S.; Pengpid, S.; Hasan, M.T.; Sessou, P.; Ditekemena, J.D.; Amodan, B.O.; et al. Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries. Vaccines 2021, 9, 515. [Google Scholar] [CrossRef]
- Ackah, M.; Ameyaw, L.; Gazali Salifu, M.; Afi Asubonteng, D.P.; Osei Yeboah, C.; Narkotey Annor, E.; Abena Kwartemaa Ankapong, E.; Boakye, H. COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis. PLoS ONE 2022, 17, e0268711. [Google Scholar] [CrossRef]
- Ennab, F.; Babar, M.S.; Khan, A.R.; Mittal, R.J.; Nawaz, F.A.; Essar, M.Y.; Fazel, S.S. Implications of social media misinformation on COVID-19 vaccine confidence among pregnant women in Africa. Clin. Epidemiol. Glob. Health 2022, 14, 100981. [Google Scholar] [CrossRef]
- Skafle, I.; Nordahl-hansen, A.; Quintana, D.S.; Wynn, R. Misinformation About COVID-19 Vaccines on Social Media: Rapid Review. J. Med. Internet Res. 2022, 24, e37367. [Google Scholar] [CrossRef] [PubMed]
- Puri, N.; Coomes, E.A.; Haghbayan, H.; Gunaratne, K. Social media and vaccine hesitancy: New updates for the era of COVID-19 and globalized infectious diseases. Hum. Vaccines Immunother. 2022, 16, 2586–2593. [Google Scholar] [CrossRef] [PubMed]
- Ennab, F.; Qasba, R.K.; Uday, U.; Priya, P.; Qamar, K.; Nawaz, F.A.; Islam, Z.; Zary, N. COVID-19 vaccine hesitancy: A narrative review of four South Asian countries. Front. Public Health 2022, 10, 997884. [Google Scholar] [CrossRef] [PubMed]
Variable | n (%) |
---|---|
Regions | |
Mbeya | 50 (13.5) |
Kilimanjaro | 47 (12.7) |
Simiyu | 41 (11.1) |
Lindi | 55 (14.9) |
Tabora | 60 (16.2) |
Dar es salaam | 39 (10.6) |
Mjini Magharibi | 31 (8.4) |
Kaskazini Pemba | 46 (12.4) |
Sex | |
Male | 116 (31.4) |
Female | 253 (68.6) |
Age range in years (min–max) | (18–94) |
Mean age (SD) in years | 40 (13.2) |
Marital Status | |
Single | 71 (19.2) |
Married | 239 (64.7) |
Separated | 22 (5.9) |
Widow | 37 (10.0) |
Educational level | |
Incomplete primary school | 31 (8.4) |
Primary school | 208 (56.4) |
Secondary school | 106 (28.7) |
Diploma/certificates | 12 (3.3) |
Higher education | 12 (3.2) |
Occupation | |
Employed | 28 (7.6) |
Self employed | 188 (50.9) |
Not employed | 105 (28.5) |
Farming | 48 (13.0) |
Vaccination status (females n = 253) | |
Vaccinated | 127 (49.8) |
Unvaccinated | 126 (50.2) |
Variable | n (%) |
---|---|
Sex | |
Male | 26 (81.3) |
Female | 6 (18.7) |
Age range in years (min–max) | 22–74 |
Mean age (SD) in years | 45.4 (13.1) |
Marital Status | |
Single | 3 (9.4) |
Married | 29 (90.6) |
Educational level | |
Incomplete primary school | 2 (8.3) |
Primary school | 6 (25.0) |
Secondary school | 7 (29.2) |
Diploma | 3 (12.5) |
Higher education | 6 (25.0) |
Occupation | |
Employed | 15 (46.9) |
Not employed | 12 (37.5) |
Self employed | 5 (15.6) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mgongo, M.B.; Manongi, R.N.; Mboya, I.B.; Ngocho, J.S.; Amour, C.; Mtei, M.; Bilakwate, J.S.; Nyaki, A.Y.; George, J.M.; Leyaro, B.J.; et al. A Qualitative Study on Barriers to COVID-19 Vaccine Uptake among Community Members in Tanzania. Vaccines 2023, 11, 1366. https://doi.org/10.3390/vaccines11081366
Mgongo MB, Manongi RN, Mboya IB, Ngocho JS, Amour C, Mtei M, Bilakwate JS, Nyaki AY, George JM, Leyaro BJ, et al. A Qualitative Study on Barriers to COVID-19 Vaccine Uptake among Community Members in Tanzania. Vaccines. 2023; 11(8):1366. https://doi.org/10.3390/vaccines11081366
Chicago/Turabian StyleMgongo, Melina Bernard, Rachel N. Manongi, Innocent B. Mboya, James S. Ngocho, Caroline Amour, Monica Mtei, Julieth S. Bilakwate, Ahmed Yusuph Nyaki, Johnston M. George, Beatrice J. Leyaro, and et al. 2023. "A Qualitative Study on Barriers to COVID-19 Vaccine Uptake among Community Members in Tanzania" Vaccines 11, no. 8: 1366. https://doi.org/10.3390/vaccines11081366
APA StyleMgongo, M. B., Manongi, R. N., Mboya, I. B., Ngocho, J. S., Amour, C., Mtei, M., Bilakwate, J. S., Nyaki, A. Y., George, J. M., Leyaro, B. J., Farah, A., Kengia, J. T., Tinuga, F., Bakari, A. H., Kirakoya, F. B., Araya, A., Kapologwe, N. A., & Msuya, S. E. (2023). A Qualitative Study on Barriers to COVID-19 Vaccine Uptake among Community Members in Tanzania. Vaccines, 11(8), 1366. https://doi.org/10.3390/vaccines11081366